BioSpace News Archive

Lineage Cell Therapeutics, Inc. and the Christopher & Dana Reeve Foundation are proud to present the 1st Annual Spinal Cord Injury Investor Symposium, a forum to discuss the recent innovation, advancements, and challenges in the treatment of spinal cord injury.

Psilera is proud to achieve a landmark preclinical milestone with 100% success.

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”) an AI-driven biotherapeutic research and technology company today announced a research collaboration and exclusive option license agreement with Xyphos Biosciences, Inc. (a wholly owned subsidiary of Astellas Pharma Inc., “Astellas”).

Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced financial results for the fourth quarter and full year ended December 31, 2022 and provided a business update.

Allogene Therapeutics, Inc., a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, published its 2022 annual ESG report.

Dyadic International, Inc. announced that its Chief Executive Officer, Mark Emalfarb will be presenting at the upcoming World Vaccine Congress in Washington, D.C.

Neuvivo today announced the publication of a peer-reviewed paper titled: “Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS”.

Acasti Pharma Inc. announced that Mr. Jean-Marie Canan had tendered his resignation from the Board of Directors of the Company, such resignation to take effect immediately.

ProSomnus, Inc., a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea, announced financial results for the fourth quarter and fiscal year ended December 31, 2022.

Evogene Ltd. announced that it filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2022 with the Securities and Exchange Commission.